Ameliorating Effect on Aβ-Induced Alzheimer's Mice by Litsea cubeba Persoon Powder.
Kuan-Tseng LeeChen-Yeon ChuShen-Shih ChiangPublished in: Molecules (Basel, Switzerland) (2021)
Alzheimer's disease (AD) is caused by excessive oxidative damage and aging. The objective of this study was to investigate the anti-dementia effect of LCP fruit powder on amyloid β (Aβ)-induced Alzheimer's mice. The composition of LCP essential oil was determined by gas chromatography/mass spectrometry. In addition, the water maze was used to evaluate the learning and memorizing abilities of the mice. The concentrations of malondialdehyde (MDA), protein carbonyl, phosphorylated τ-protein, and the deposition of Aβ plaques in mouse brains were also assessed. The results showed that the main components of essential oils in LCP and d-limonene, neral, and geranial contents were 14.15%, 30.94%, and 31.74%, respectively. Furthermore, oral administration with different dosages of LCP significantly decreased the escape time (21.25~33.62 s) and distance (3.23~5.07 m) in the reference memory test, and increased the duration time (26.14~28.90 s) and crossing frequency (7.00~7.88 times) in the target zone of probe test (p < 0.05). LCP also inhibited the contents of MDA and the phosphor-τ-protein from oxidative stress, reduced the brain atrophy by about 3~8%, and decreased the percentage of Aβ plaques from 0.44 to 0.05%. Finally, it was observed that the minimum dosage of LCP fruit powder (LLCP, 30.2 mg/day) could prevent oxidative stress induced by Aβ and subsequently facilitate memory and learning deficits in Aβ-induced neurotoxicity and cognitively impaired mice.
Keyphrases
- diabetic rats
- oxidative stress
- cognitive decline
- high fat diet induced
- high glucose
- gas chromatography mass spectrometry
- mild cognitive impairment
- working memory
- dna damage
- traumatic brain injury
- amino acid
- ischemia reperfusion injury
- protein protein
- type diabetes
- small molecule
- breast cancer cells
- physical activity
- body mass index
- blood brain barrier
- binding protein
- metabolic syndrome
- cell proliferation
- mass spectrometry
- multiple sclerosis
- brain injury
- single molecule
- gas chromatography